AmSurg Reports First-Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Jefferies Has Bullish View on AmSurg (AMSG) Post Q1; PT Raised to $76
May 6, 2015 9:35 AM EDTJefferies maintains a Buy rating for AmSurg (NASDAQ: AMSG) and raises the price target to $76 (from $68). It is believed that the earnings and growth that came along with the recent acquisition of Sheridan, along with ongoing improvements, will drive multiple expansions over the next 12... More
Amsurg (AMSG) Tops Q1 EPS by 5c, Raises FY Guidance
May 5, 2015 4:33 PM EDTAmsurg (NASDAQ: AMSG) reported Q1 EPS of $0.62, $0.05 better than the analyst estimate of $0.57. Revenue for the quarter came in at $570.4 million versus the consensus estimate of $574.3 million.
Amsurg sees FY2015 EPS of $3.31-$3.39, versus prior guidance of $3.24-$3.32 and the consensus of $3.26. Amsurg... More
